Cell Design Labs logo

Cell Design Labs

A biotechnology company founded in 2015 which operates as a subsidiary of Gilead Sciences and Kite Pharma. The company developed a platform for custom cell engineering called synNotch to be used for anticancer therapies. Their system can also be used to develop cell-based therapies for autoimmune and degenerative disorders.

1

Funding Rounds

$34.4m

Money raised

Overview

A biotechnology company founded in 2015 which operates as a subsidiary of Gilead Sciences and Kite Pharma. The company developed a platform for custom cell engineering called synNotch to be used for anticancer therapies. Their system can also be used to develop cell-based therapies for autoimmune and degenerative disorders.

Industries

Cell Design Labs is active in the following industries:
  • Cell therapy
  • Oncology
  • Therapeutics
  • Genetic engineering
  • Immunotherapy
  • Cancer immunotherapy
  • Therapy
  • Cancer
  • Autoimmune disease
  • Technology
  • Synthetic biology
  • Biology
  • Biotechnology
  • Internal medicine
  • Healthcare
  • Regenerative medicine
  • Medicine
  • Allogeneic cell therapy